Owlet (NYSE:OWLT – Get Free Report) and Envoy Medical (NASDAQ:COCH – Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, risk, institutional ownership, analyst recommendations, earnings, profitability and dividends.
Insider & Institutional Ownership
72.6% of Owlet shares are held by institutional investors. Comparatively, 8.6% of Envoy Medical shares are held by institutional investors. 36.2% of Owlet shares are held by company insiders. Comparatively, 7.2% of Envoy Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Earnings & Valuation
This table compares Owlet and Envoy Medical”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Owlet | $105.70 million | 1.14 | -$39.68 million | ($0.75) | -5.48 |
| Envoy Medical | $240,000.00 | 180.75 | -$23.76 million | ($0.76) | -0.74 |
Envoy Medical has lower revenue, but higher earnings than Owlet. Owlet is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.
Risk & Volatility
Owlet has a beta of 1.91, meaning that its share price is 91% more volatile than the S&P 500. Comparatively, Envoy Medical has a beta of 1.97, meaning that its share price is 97% more volatile than the S&P 500.
Profitability
This table compares Owlet and Envoy Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Owlet | -8.61% | -601.24% | -15.96% |
| Envoy Medical | -11,304.83% | N/A | -144.13% |
Analyst Recommendations
This is a breakdown of current ratings and recommmendations for Owlet and Envoy Medical, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Owlet | 1 | 1 | 3 | 0 | 2.40 |
| Envoy Medical | 1 | 1 | 2 | 0 | 2.25 |
Owlet presently has a consensus price target of $15.00, suggesting a potential upside of 264.87%. Envoy Medical has a consensus price target of $2.17, suggesting a potential upside of 285.53%. Given Envoy Medical’s higher probable upside, analysts plainly believe Envoy Medical is more favorable than Owlet.
Summary
Owlet beats Envoy Medical on 8 of the 14 factors compared between the two stocks.
About Owlet
Owlet, Inc. provides digital parenting solutions in the United States and internationally. The company's platform focuses on giving real-time data and insights to parents. It offers Dream Sock, a wearable infant health monitor equipped with pulse oximetry technology to track vitals signs, such as pulse rate, oxygen, activity, and sleep patterns; BabySat which is intended for infants with heightened health risk; Owlet Cam, a monitoring device in smartphones that offers video and audio, predictive sleep insights, and cry detections; and accessories, including Owlet Sleeper, as well as Duo and Dream Duo that combines Smart Sock with the Owlet Cam. The company was founded in 2012 and is headquartered in Lehi, Utah.
About Envoy Medical
Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.
Receive News & Ratings for Owlet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owlet and related companies with MarketBeat.com's FREE daily email newsletter.
